Strs Ohio Dynavax Technologies Corp Transaction History

Strs Ohio

$26.2 Billion
Q3 2025

A detailed history of Strs Ohio transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Strs Ohio holds 61,700 shares of DVAX stock, worth $641,680. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,700

Previous 20,800 196.63%

Holding current value

$641,680

Previous $206,000 197.09%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 30, 2025	BUY	$9.36 - $11.36 $382,824 - $464,624	40,900 Added 196.63%	61,700 $612,000
Q2 2025 Aug 04, 2025	BUY	$9.4 - $12.87 $14,100 - $19,305	1,500 Added 7.77%	20,800 $206,000
Q2 2024 Aug 05, 2024	SELL	$10.73 - $12.58 $431,346 - $505,716	-40,200 Reduced 67.56%	19,300 $216,000
Q1 2024 May 13, 2024	SELL	$11.7 - $14.98 $28,080 - $35,952	-2,400 Reduced 3.88%	59,500 $738,000
Q4 2023 Jan 30, 2024	SELL	$13.09 - $14.98 $24,871 - $28,462	-1,900 Reduced 2.98%	61,900 $865,000
Q3 2023 Oct 26, 2023	SELL	$12.64 - $14.99 $20,224 - $23,984	-1,600 Reduced 2.45%	63,800 $942,000
Q2 2023 Jul 31, 2023	SELL	$9.85 - $13.17 $71,905 - $96,141	-7,300 Reduced 10.04%	65,400 $844,000
Q1 2023 Aug 02, 2023	BUY	$9.44 - $11.88 $68,912 - $86,724	7,300 Added 11.16%	72,700 $713,000
Q1 2023 Apr 27, 2023	BUY	$9.44 - $11.88 $39,648 - $49,896	4,200 Added 6.13%	72,700 $713,000
Q4 2022 Jan 26, 2023	SELL	$10.27 - $13.29 $63,674 - $82,398	-6,200 Reduced 8.3%	68,500 $728,000
Q3 2022 Oct 27, 2022	BUY	$9.93 - $17.44 $13,902 - $24,416	1,400 Added 1.91%	74,700 $779,000
Q2 2022 Jul 25, 2022	BUY	$7.45 - $12.83 $357,600 - $615,840	48,000 Added 189.72%	73,300 $922,000
Q3 2021 Oct 22, 2021	BUY	$9.16 - $19.83 $231,748 - $501,698	25,300 New	25,300 $486,000

Others Institutions Holding DVAX

# of Institutions

293

Shares Held

120M

Call Options Held

294K

Put Options Held

86.1K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.32B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account